Monday , December 11 2017
Home / Resources / Clinical Presentations / Insulin Degludec

Insulin Degludec

DCMS110HS

With last week’s news that the FDA’s Endocrinologic and Metabolic Drugs Advisory Committee has recommended the approval of degludec, we thought we’d give you an overview of this new drug’s pharmacology, the current approval status, trial results, and some of the cardiovascular safety concerns around degludec….

Link to download (.ppt format): Insulin Degludec

 

Check out all of Diabetes In Control’s slide collections at our Clinical Presentations Library.